|
1
|
Rotterdam ESHRE/ASRM-sponsored PCOS
consensus workshop group: Revised 2003 consensus on diagnostic
criteria and long-term health risks related to polycystic ovary
syndrome (PCOS). Hum Reprod. 19:41–47. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Morin-Papunen LC, Vauhkonen I, Koivunen
RM, Ruokonen A and Tapanainen JS: Insulin sensitivity, insulin
secretion, and metabolic and hormonal parameters in healthy women
and women with polycystic ovarian syndrome. Hum Reprod.
15:1266–1274. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ehrmann DA and Rychlik D: Pharmacologic
treatment of polycystic ovary syndrome. Semin Reprod Med.
21:277–283. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Torchen LC: Cardiometabolic risk in PCOS:
More than a reproductive disorder. Curr Diab Rep. 17:1372017.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bortoluzzi S, Scannapieco P, Cestaro A,
Danieli GA and Schiaffino S: Computational reconstruction of the
human skeletal muscle secretome. Proteins. 62:776–792. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yoon JH, Yea K, Kim J, Choi YS, Park S,
Lee H, Lee CS, Suh PG and Ryu SH: Comparative proteomic analysis of
the insulin-induced L6 myotube secretome. Proteomics. 9:51–60.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Henningsen J, Rigbolt KT, Blagoev B,
Pedersen BK and Kratchmarova I: Dynamics of the skeletal muscle
secretome during myoblast differentiation. Mol Cell Proteomics.
9:2482–2496. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
McPherron AC, Lawler AM and Lee SJ:
Regulation of skeletal muscle mass in mice by a new TGF-beta
superfamily member. Nature. 387:83–90. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sharma M, Kambadur R, Matthews KG, Somers
WG, Devlin GP, Conaglen JV, Fowke PJ and Bass JJ: Myostatin, a
transforming growth factor-beta superfamily member, is expressed in
heart muscle and is upregulated in cardiomyocytes after infarct. J
Cell Physiol. 180:1–9. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Amirouche A, Durieux AC, Banzet S,
Koulmann N, Bonnefoy R, Mouret C, Bigard X, Peinnequin A and
Freyssenet D: Down-regulation of Akt/mammalian target of rapamycin
signaling pathway in response to myostatin overexpression in
skeletal muscle. Endocrinology. 150:286–294. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Durieux AC, Amirouche A, Banzet S,
Koulmann N, Bonnefoy R, Pasdeloup M, Mouret C, Bigard X, Peinnequin
A and Freyssenet D: Ectopic expression of myostatin induces atrophy
of adult skeletal muscle by decreasing muscle gene expression.
Endocrinology. 148:3140–3147. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lee SJ, Reed LA, Davies MV, Girgenrath S,
Goad ME, Tomkinson KN, Wright JF, Barker J, Ehrmantraut G,
Holmstrom J, et al: Regulation of muscle growth by multiple ligands
signaling through activin type II receptors. Proc Natl Acad Sci
USA. 102:18117–18122. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lee SJ: Extracellular regulation of
myostatin: A molecular rheostat for muscle mass. Immunol Endocr
Metab Agents Med Chem. 10:183–194. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Park JJ, Berggren JR, Hulver MW, Houmard
JA and Hoffman EP: GRB14, GPD1, and GDF8 as potential network
collaborators in weight loss-induced improvements in insulin action
in human skeletal muscle. Physiol Genomics. 27:114–121. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Argilés JM, Orpí M, Busquets S and
López-Soriano FJ: Myostatin: More than just a regulator of muscle
mass. Drug Discov Today. 17:702–709. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Taylor WE, Bhasin S, Artaza J, Byhower F,
Azam M, Willard, DH Jr, Kull FC Jr and Gonzalez-Cadavid N:
Myostatin inhibits cell proliferation and protein synthesis in
C2C12 muscle cells. Am J Physiol Endocrinol Metab. 280:E221–E228.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hittel DS, Berggren JR, Shearer J, Boyle K
and Houmard JA: Increased secretion and expression of myostatin in
skeletal muscle from extremely obese women. Diabetes. 58:30–38.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Islam MS, Catherino WH, Protic O,
Janjusevic M, Gray PC, Giannubilo SR, Ciavattini A, Lamanna P,
Tranquilli AL, Petraglia F, et al: Role of activin-A and myostatin
and their signaling pathway in human myometrial and leiomyoma cell
function. J Clin Endocrinol Metab. 99:E775–E785. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Guo J, Tian T, Lu D, Xia G, Wang H and
Dong M: Alterations of maternal serum and placental
follistatin-like 3 and myostatin in pre-eclampsia. J Obstet
Gynaecol Res. 38:988–996. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen MJ, Han DS, Yang JH, Yang YS, Ho HN
and Yang WS: Myostatin and its association with abdominal obesity,
androgen and follistatin levels in women with polycystic ovary
syndrome. Hum Reprod. 27:2476–2483. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
McMahon CD, Popovic L, Jeanplong F, Oldham
JM, Kirk SP, Osepchook CC, Wong KW, Sharma M, Kambadur R and Bass
JJ: Sexual dimorphism is associated with decreased expression of
processed myostatin in males. Am J Physiol Endocrinol Metab.
284:E377–E381. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bonala S, Lokireddy S, McFarlane C, Patnam
S, Sharma M and Kambadur R: Myostatin induces insulin resistance
via Casitas B-lineage lymphoma b (Cblb)-mediated degradation of
insulin receptor substrate 1 (IRS1) protein in response to high
calorie diet intake. J Biol Chem. 289:7654–7670. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hittel DS, Axelson M, Sarna N, Shearer J,
Huffman KM and Kraus WE: Myostatin decreases with aerobic exercise
and associates with insulin resistance. Med Sci Sports Exerc.
42:2023–2029. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Toloza FJK, Mantilla-Rivas JO, Pérez-Matos
MC, Ricardo-Silgado ML, Morales-Alvarez MC, Pinzón-Cortés JA,
Pérez-Mayorga M, Arévalo-Garcia ML, Tolosa-González G and Mendivil
CO: Plasma levels of myonectin but not myostatin or FGF-21 are
associated with insulin resistance in adult humans without diabetes
mellitus. Front Endocrinol (Lausanne). 9:52018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hjorth M, Pourteymour S, Görgens SW,
Langleite TM, Lee S, Holen T, Gulseth HL, Birkeland KI, Jensen J,
Drevon CA and Norheim F: Myostatin in relation to physical activity
and dysglycaemia and its effect on energy metabolism in human
skeletal muscle cells. Acta Physiol (Oxf). 217:45–60. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Brandt C, Nielsen AR, Fischer CP, Hansen
J, Pedersen BK and Plomgaard P: Plasma and muscle myostatin in
relation to type 2 diabetes. PLoS One. 7:e372362012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ferriman D and Gallwey JD: Clinical
assessment of body hair growth in women. J Clin Endocrinol Metab.
21:1440–1447. 1961. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Matthews DR, Hosker JP, Rudenski AS,
Naylor BA, Treacher DF and Turner RC: Homeostasis model assessment:
Insulin resistance and β-cell function from fasting plasma glucose
and insulin concentrations in man. Diabetologia. 28:412–419. 1985.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Schafer MJ, Atkinson EJ, Vanderboom PM,
Kotajarvi B, White TA, Moore MM, Bruce CJ, Greason KL, Suri RM,
Khosla S, et al: Quantification of GDF11 and myostatin in human
aging and cardiovascular disease. Cell Metab. 23:1207–1215. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Nguyen MH, Cheng M and Koh TJ: Impaired
muscle regeneration in ob/ob and db/db mice.
ScientificWorldJournal. 11:1525–1535. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Han DS, Chu-Su Y, Chiang CK, Tseng FY,
Tseng PH, Chen CL, Wu KD and Yang WS: Serum myostatin is reduced in
individuals with metabolic syndrome. PLoS One. 9:e1082302014.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Camporez JPG, Petersen MC, Abudukadier A,
Moreira GV, Jurczak MJ, Friedman G, Haqq CM, Petersen KF and
Shulman GI: Anti-myostatin antibody increases muscle mass and
strength and improves insulin sensitivity in old mice. Proc Natl
Acad Sci USA. 113:2212–2217. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Palsgaard J, Brøns C, Friedrichsen M,
Dominguez H, Jensen M, Storgaard H, Spohr C, Torp-Pedersen C, Borup
R, De Meyts P and Vaag A: Gene expression in skeletal muscle
biopsies from people with type 2 diabetes and relatives:
Differential regulation of insulin signaling pathways. PLoS One.
4:e65752009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Goodman NF, Cobin RH, Futterweit W, Glueck
JS, Legro RS and Carmina E: American Association of
ClinicalEndocrinologists (AACE); American College of Endocrinology
(ACE); Androgen Excess and PCOS Society: American association of
clinical endocrinologists, American college of endocrinology, and
androgen excess and PCOS society disease state clinical review:
Guide to the best practices in the evaluation and treatment of
polycystic ovary syndrome-part 2. Endocr Pract. 21:1415–1426. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Helene HDN: Androgens and the molecular
regulation of skeletal muscle mass. Doctoral dissertation, Gent
University; Gent, Belgium: 2014, https://biblio.ugent.be/publication/4411710/file/4411749
|
|
36
|
Kogure GS, Miranda-Furtado CL, Silva RC,
Melo AS, Ferriani RA, De Sá MF and Dos Reis RM: Resistance exercise
impacts lean muscle mass in women with polycystic ovary syndrome.
Med Sci Sports Exerc. 48:589–598. 2016. View Article : Google Scholar : PubMed/NCBI
|
